PureIMS Alternatives & Competitors
12 companies similar to PureIMS — 🫁 Improving the health and lives of patients through effective, safe and conven...
Companies similar to PureIMS
Gensenta İlaç
Köklü Geçmişimizden, Sağlığın Geleceğine...
Turkey
BridgeBio
We move at the speed of patient need.
Palo Alto, United States
Novoron Bioscience
Pioneering lipoprotein-receptor drug development to repair damage and degeneration to the...
San Diego, United States
Sudo Biosciences
Developing precision TYK2 therapeutics.
Carmel, United States
Track all PureIMS competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Ensoma
The future of medicine lies within us.
Boston, United States
Gandeeva Therapeutics
Gandeeva Therapeutics uses the most advanced cryo-EM and computational tools to develop be...
Canada
Intract Pharma
Transforming Patient Care by Replacing Injections with Safer, More Effective Therapeutics...
London, United Kingdom
Octant
Developing synthetic technology and applying next-generation DNA sequencing, gene synthesi...
Emeryville, United States
Absci
Unlocking differentiated biology with generative AI
Vancouver, United States
Via Nova Therapeutics
An antiviral startup focusing on acute and subacute viral infections for which therapies a...
Berkeley, United States
Sana Biotechnology, Inc.
Focused on creating and delivering engineered cells as medicines for patients
Seattle, United States
About PureIMS
PureIMS is a promising clinical stage pharmaceutical company established in 2014 in The Netherlands. With a focus on innovative inhaled therapies utilizing its proprietary dry powder inhaler, Cyclops®, the company aims to address systemic and respiratory diseases with high unmet medical needs. Its commitment is encapsu...
Development of Dry Powder Inhalers, Pharmaceutical Product Manufacturing, Drug Delivery System Innovation, Co-development with Pharma Partners
Patients with Respiratory Conditions, Healthcare Providers, Pharmaceutical Companies, Medical Device Distributors
Inhaled Drug Delivery, Dry Powder Inhaler Technology, Cyclops® Inhaler, Systemic Disease Treatment, Respiratory Disease Treatment, Parkinson's Disease Therapy, Cystic Fibrosis Treatment, Named Patient Program, Anaphylaxis Therapy, Strategic Licensing Partnerships, Pharmaceutical Commercialization, Clinical-stage Pharmaceuticals, Pharmaceutical Innovation, Inhalation Route For Drugs, Drug Development Leadership
B2B, B2C, B2B2C
Product Sales, Licensing, Service Fee
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches PureIMS and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at PureIMS on 13 Nov 2025. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
